世界の細胞・遺伝子治療市場は2023年に約126億2,000万米ドルと評価され、2024年から2032年の予測期間中に18.04%の年間複合成長率（CAGR）を示しています。
細胞・遺伝子治療は、細胞レベルまたは遺伝子レベルで遺伝性疾患および病気に対処し、治癒する可能性を秘めた高度な医療処置です。細胞治療では、生きた細胞を注入または移植して損傷した組織や臓器を修復または置換します。たとえば、白血病などの疾患では幹細胞を使用して細胞を再生します。一方、遺伝子治療は、患者の細胞内に遺伝物質を挿入、変更、または除去することで、疾患の原因となる欠陥遺伝子を修正または修正することを目的としています。がんや希少疾患の発生率の急増と、細胞・遺伝子治療製品の承認の増加により、市場の成長が大幅に促進されています。さらに、細胞・遺伝子治療分野への投資の増加により、将来的に十分な成長機会が提供されると予想されています。
がんや希少疾患の発生率の増加は、細胞・遺伝子治療市場の需要を大幅に押し上げています。これらの疾患の世界的な蔓延が進むにつれて、従来の治療法では不十分なことが多くなり、革新的なソリューションが緊急に必要になっています。細胞・遺伝子治療は、これらの疾患の根本的な遺伝的および細胞的原因に対処することで、標的を絞った潜在的に治癒的なアプローチを提供します。がんの場合、治療は特定のがん細胞を標的にすることができますが、希少疾患の場合は、遺伝子編集または置換により遺伝子欠陥を修正できます。効果的な治療に対するニーズの高まりは、高度な治療への投資と研究を刺激し、市場の成長を促進します。患者の転帰を改善するパーソナライズされた精密医療の約束は、細胞・遺伝子治療セクターの拡大をさらに促進します。
世界の細胞・遺伝子治療市場の主要地域には、北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東・アフリカが含まれます。2023年には、慢性疾患の蔓延、償還の利用可能性、遺伝子治療薬への多額のヘルスケア支出によって、北アメリカが収益面で市場を独占します。アメリカが北アメリカ市場を独占し、かなりのシェアを占めています。アジア太平洋地域は、人口が多く、ヘルスケアに対する意識が高く、がん患者が増加していることから、最も高いCAGRで成長すると予測されています。この地域の成長は、医薬品市場の拡大、政府のイニシアティブ、研究開発活動の急増によってさらに支えられています。
目次
Table of Contents
Chapter 1. Global Cell and Gene Therapy Market Executive Summary
1.1. Global Cell and Gene Therapy Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Therapy Type
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cell and Gene Therapy Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cell and Gene Therapy Market Dynamics
3.1. Market Drivers
3.1.1. Growing Incidences of Cancer and Rare Disorders
3.1.2. Increasing Approval for Gene and Cell Therapy Products
3.1.3. Growing Investments in the Field of Cell and Gene Therapy
3.2. Market Challenges
3.2.1. High Cost of Treatment
3.2.2. Complexity of Regulatory Approvals
3.3. Market Opportunities
3.3.1. Technological Advancements
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Cell and Gene Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cell and Gene Therapy Market Size & Forecasts by Therapy Type 2022-2032
5.1. Segment Dashboard
5.2. Global Cell and Gene Therapy Market: Therapy Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Cell Therapy
5.2.2. Gene Therapy
5.2.2.1. Autologous
5.2.2.2. Allogenic
5.2.2.3. Ex-vivo
5.2.2.4. In-vivo
Chapter 6. Global Cell and Gene Therapy Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Cell and Gene Therapy Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cancer
6.2.2. Neurological Disorders
6.2.3. Cardiovascular Disorders
6.2.4. Rare Diseases
6.2.5. Ophthalmology
6.2.6. Blood Disorders
6.2.7. Others
Chapter 7. Global Cell and Gene Therapy Market Size & Forecasts by Region 2022-2032
7.1. North America Cell and Gene Therapy Market
7.1.1. U.S. Cell and Gene Therapy Market
7.1.1.1. Therapy Type breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Cell and Gene Therapy Market
7.2. Europe Cell and Gene Therapy Market
7.2.1. UK Cell and Gene Therapy Market
7.2.2. Germany Cell and Gene Therapy Market
7.2.3. France Cell and Gene Therapy Market
7.2.4. Spain Cell and Gene Therapy Market
7.2.5. Italy Cell and Gene Therapy Market
7.2.6. Rest of Europe Cell and Gene Therapy Market
7.3. Asia-Pacific Cell and Gene Therapy Market
7.3.1. China Cell and Gene Therapy Market
7.3.2. India Cell and Gene Therapy Market
7.3.3. Japan Cell and Gene Therapy Market
7.3.4. Australia Cell and Gene Therapy Market
7.3.5. South Korea Cell and Gene Therapy Market
7.3.6. Rest of Asia Pacific Cell and Gene Therapy Market
7.4. Latin America Cell and Gene Therapy Market
7.4.1. Brazil Cell and Gene Therapy Market
7.4.2. Mexico Cell and Gene Therapy Market
7.4.3. Rest of Latin America Cell and Gene Therapy Market
7.5. Middle East & Africa Cell and Gene Therapy Market
7.5.1. Saudi Arabia Cell and Gene Therapy Market
7.5.2. South Africa Cell and Gene Therapy Market
7.5.3. Rest of Middle East & Africa Cell and Gene Therapy Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Bristol-Myers Squibb Company
8.3.3. Amgen Inc.
8.3.4. Aurion Biotech
8.3.5. Sarepta Therapeutics, Inc.
8.3.6. Ferring B.V.
8.3.7. Sibiono Genetech Co, Ltd., Shenzhen
8.3.8. Bluebird Bio, Inc.
8.3.9. Kite Pharmaceuticals, Inc.
8.3.10. Janssen Global Services
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Global Cell and Gene Therapy market, report scope
TABLE 2. Global Cell and Gene Therapy market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Cell and Gene Therapy market estimates & forecasts by Therapy Type 2022-2032 (USD Billion)
TABLE 4. Global Cell and Gene Therapy market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 5. Global Cell and Gene Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Cell and Gene Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Cell and Gene Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Cell and Gene Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Cell and Gene Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Cell and Gene Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Cell and Gene Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Cell and Gene Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Cell and Gene Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Cell and Gene Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Cell and Gene Therapy market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Cell and Gene Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Cell and Gene Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Cell and Gene Therapy market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Cell and Gene Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Cell and Gene Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Cell and Gene Therapy market, research methodology
FIG 2. Global Cell and Gene Therapy market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Cell and Gene Therapy market, key trends 2023
FIG 5. Global Cell and Gene Therapy market, growth prospects 2022-2032
FIG 6. Global Cell and Gene Therapy market, porters 5 force model
FIG 7. Global Cell and Gene Therapy market, PESTEL analysis
FIG 8. Global Cell and Gene Therapy market, value chain analysis
FIG 9. Global Cell and Gene Therapy market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Cell and Gene Therapy market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Cell and Gene Therapy market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Cell and Gene Therapy market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Cell and Gene Therapy market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Cell and Gene Therapy market, regional snapshot 2022 & 2032
FIG 15. North America Cell and Gene Therapy market 2022 & 2032 (USD Billion)
FIG 16. Europe Cell and Gene Therapy market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Cell and Gene Therapy market 2022 & 2032 (USD Billion)
FIG 18. Latin America Cell and Gene Therapy market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Cell and Gene Therapy market 2022 & 2032 (USD Billion)
FIG 20. Global Cell and Gene Therapy market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
